FDA WON’T RE-SCHEDULE MARIJUANA BUT WILL ALLOW RESEARCH

The FDA has decided that it will not re-schedule marijuana under the Federal Controlled Substance Act but will allow more research of marijuana.   After months of speculation of whether the FDA would reschedule marijuana from a Schedule I drug to a Schedule II, the FDA is electing to take this half-hearted measure. The Federal government’s … Continue reading FDA WON’T RE-SCHEDULE MARIJUANA BUT WILL ALLOW RESEARCH

The DEA is Closer to a Decision on Whether To Reschedule Marijuana Under the Control Substance Act.

In a statement made to The Cannabist on August 2, 2016, DEA Agent Russ Baer said that the DEA was closer than they were a month ago in making a decision with regards to rescheduling.  Earlier this year, the DEA issued a statement that they wished to have decision on rescheduling made by the first half … Continue reading The DEA is Closer to a Decision on Whether To Reschedule Marijuana Under the Control Substance Act.

While the Laws are Changing in Pennsylvania, Possession of Marijuana For Personal Use Remains a Crime.

Overshadowed by the enactment of Pennsylvania’s Medical Marijuana Act (“MMA”)in April is a bill introduce on May 17, 2016, by House Representative Ed Gainey which called for the amendment of Pennsylvania’s Controlled Substance Act, Drug, Device and Cosmetic Act, 35 P.S. 780-101 et. Seq. (“CSA”). Specifically, HB 2076 seeks to amend PA’s CSA by reducing the … Continue reading While the Laws are Changing in Pennsylvania, Possession of Marijuana For Personal Use Remains a Crime.

The Department Of Justice’s Policy On Marijuana And Its Affects On Financing For Marijuana Related Businesses

As most readers of this blog are aware, marijuana is now legal in some form in half of the states, including Pennsylvania. Although legal in half of the states, marijuana related businesses remain subject to federal prosecution under the Controlled Substance Act (“CSA”) because it remains listed as a Schedule I drug. Until the DEA … Continue reading The Department Of Justice’s Policy On Marijuana And Its Affects On Financing For Marijuana Related Businesses

Governor Wolf passes new law allowing research into industrial hemp.

Pennsylvania has taken another step forward in legitimizing the production of Cannabis. In this instance, it's industrial hemp. On July 19, 2016, Governor Tom Wolf signed a new law providing for industrial hemp research. House Bill No. 967, now Act 92 was approved by Governor Wolf and amends Title 3 (Agriculture) of the Pennsylvania Consolidated … Continue reading Governor Wolf passes new law allowing research into industrial hemp.

Pennsylvania’s Department of Health sets up a Physician’s Work Group to aid in the implementation of the Medical Marijuana Program.

On Tuesday, July 19, 2016, the Pennsylvania Department of Health took another step forward in the implementation of the state’s Medical Marijuana Act by establishing a Physician’s Work Group. Pennsylvania Secretary of Health, Dr. Karen Murphy, in an announcement from the DOH, said, "We have started working closely with physician groups to disseminate important information, … Continue reading Pennsylvania’s Department of Health sets up a Physician’s Work Group to aid in the implementation of the Medical Marijuana Program.

FICG Files Comment in Opposition to ATF’s Proposed Changes to the 4473 Form

Today, Attorney Adam Kraut and Chief Counsel Joshua Prince of Firearms Industry Consulting Group® ("FICG®"), a division of Prince Law Offices, P.C., filed a Comment in Opposition to numerous changes that the Bureau of Alcohol, Tobacco, Firearms and Explosives proposed to the 4473 Form. FICG® raised a plethora of issues, including that ATF is the … Continue reading FICG Files Comment in Opposition to ATF’s Proposed Changes to the 4473 Form

PA’s Medical Marijuana Act awaits the Governor’s signature

After years of waiting and numerous amendments to Senate Bill 3 (“SB3”) Pennsylvania is one step away from legalizing medical marijuana. SB3 was approved by the Senate last May by a 40-7 vote. Earlier this year, the House significantly amended SB3 and approved the amended SB3 by 149-43 vote. The amended SB3 was then sent … Continue reading PA’s Medical Marijuana Act awaits the Governor’s signature

PA House Amendments to The Medical Marijuana Act.

On Wednesday March 16, 2016, the House overwhelmingly passed SB3, which had languished in two House Committees before finally being submitted for approval to the House last week. SB3 was significantly amended and both the House and Senate must pass a bill containing the same text before it may be submitted to Governor Tom Wolf … Continue reading PA House Amendments to The Medical Marijuana Act.

SPECIFIC PROTECTIONS AND PROHIBITONS FOR PATIENTS UNDER PENNSYLVANIA’S MEDICAL CANNABIS ACT

In my previous blog, I note that as a result of the restrictions and expense, medical cannabis (“MC”) patients may elect to purchase marijuana illegal. The most obvious benefit to being a registered MC patient is that you are free from arrest for use, transportation and/or possession of MC so long as the individual is … Continue reading SPECIFIC PROTECTIONS AND PROHIBITONS FOR PATIENTS UNDER PENNSYLVANIA’S MEDICAL CANNABIS ACT